Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Onconova Therapeutics Inc Announces Closing Of Initial Public Offering And Full Exercise Of Over-allotment Option

Tuesday, 30 Jul 2013 04:05pm EDT 

Onconova Therapeutics Inc announced that the closing of its initial public offering of 5,941,667 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts, including 775,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the same price to cover over-allotments. As a result, aggregate net proceeds to the Company, after underwriting discounts and commissions and other estimated offering expenses, were approximately $79.6 million. Citigroup and Leerink Swann acted as joint bookrunning managers for the offering. Piper Jaffray and Janney Montgomery Scott acted as co-managers. 

Company Quote

0.02 +0.89%
4 Mar 2015